Aveanna Healthcare Hldgs Q1 2024 Adj EPS $(0.03) Beats $(0.05) Estimate, Sales $490.653M Beat $483.976M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aveanna Healthcare Holdings (NASDAQ:AVAH) reported Q1 2024 adjusted EPS of $(0.03), surpassing the $(0.05) estimate, with sales of $490.653M exceeding the $483.976M forecast. This represents a 40% improvement in EPS and a 5.20% increase in sales year-over-year.
May 09, 2024 | 10:25 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aveanna Healthcare Holdings reported a smaller loss per share and higher sales than expected for Q1 2024, indicating a positive performance trend.
Beating both EPS and sales estimates typically generates positive investor sentiment, potentially leading to a short-term increase in stock price. The significant improvement over the previous year's performance further strengthens the case for a positive impact.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100